women must have newly diagnosed histologically or cytologically confirmed endometrial cancer
Item
women must have newly diagnosed histologically or cytologically confirmed endometrial cancer
boolean
C0086287 (UMLS CUI [1,1])
C0476089 (UMLS CUI [1,2])
C1518321 (UMLS CUI [1,3])
C0449575 (UMLS CUI [1,4])
C0086287 (UMLS CUI [2,1])
C0476089 (UMLS CUI [2,2])
C1518321 (UMLS CUI [2,3])
C0205471 (UMLS CUI [2,4])
women should have received no prior therapy for their disease
Item
women should have received no prior therapy for their disease
boolean
C0086287 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
women who are planning to undergo hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy for the management of their endometrial cancer
Item
women who are planning to undergo hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy for the management of their endometrial cancer
boolean
C0086287 (UMLS CUI [1,1])
C0020699 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0086287 (UMLS CUI [2,1])
C0195495 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0086287 (UMLS CUI [3,1])
C0193883 (UMLS CUI [3,2])
C1301732 (UMLS CUI [3,3])
women must have the ability to understand and the willingness to sign a written informed consent document
Item
women must have the ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
women who are receiving any other investigational agents
Item
women who are receiving any other investigational agents
boolean
C0086287 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
women with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to isosulfan blue or indocyanine green or other agents used in this study
Item
women with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to isosulfan blue or indocyanine green or other agents used in this study
boolean
C1527304 (UMLS CUI [1,1])
C0063908 (UMLS CUI [1,2])
C1706082 (UMLS CUI [1,3])
C0486616 (UMLS CUI [1,4])
C2348205 (UMLS CUI [1,5])
C1527304 (UMLS CUI [2,1])
C0021234 (UMLS CUI [2,2])
C1706082 (UMLS CUI [2,3])
C0486616 (UMLS CUI [2,4])
C2348205 (UMLS CUI [2,5])
C1527304 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
C1521826 (UMLS CUI [3,3])
C1706082 (UMLS CUI [3,4])
C0486616 (UMLS CUI [3,5])
C2348205 (UMLS CUI [3,6])
women with hypersensitivity to phenylmethane compounds, or a history of allergic reaction to iodides
Item
women with hypersensitivity to phenylmethane compounds, or a history of allergic reaction to iodides
boolean
C0086287 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0650066 (UMLS CUI [1,3])
C1706082 (UMLS CUI [1,4])
C0262926 (UMLS CUI [2,1])
C1527304 (UMLS CUI [2,2])
C0021966 (UMLS CUI [2,3])
patients with uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
Item
patients with uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [1,3])
C0742758 (UMLS CUI [1,4])
C0002965 (UMLS CUI [1,5])
C0003811 (UMLS CUI [1,6])
C0004936 (UMLS CUI [1,7])
C0439801 (UMLS CUI [1,8])
C0525058 (UMLS CUI [1,9])
C0748872 (UMLS CUI [1,10])
women with a history of prior loop electrosurgical excision procedure (leep) or cone procedures performed on their cervix
Item
women with a history of prior loop electrosurgical excision procedure (leep) or cone procedures performed on their cervix
boolean
C0086287 (UMLS CUI [1,1])
C4039811 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C0007874 (UMLS CUI [1,4])
C0086287 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0195324 (UMLS CUI [2,3])
C0007874 (UMLS CUI [2,4])
women with a history of lymphedema, lymphoma, or lymphatic hyperplasia (castleman disease)
Item
women with a history of lymphedema, lymphoma, or lymphatic hyperplasia (castleman disease)
boolean
C0086287 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0024236 (UMLS CUI [1,3])
C0086287 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C0086287 (UMLS CUI [3,1])
C0262926 (UMLS CUI [3,2])
C0017531 (UMLS CUI [3,3])
women with a history of a prior malignancy
Item
women with a history of a prior malignancy
boolean
C0086287 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
women may also be excluded at the discretion of their surgeon if he or she feels that the patient is not an appropriate candidate
Item
women may also be excluded at the discretion of their surgeon if he or she feels that the patient is not an appropriate candidate
boolean
C1302261 (UMLS CUI [1,1])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])